Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility
ConclusionThese observations present a novel β1AR-NOS3 signalling pathway to promote cardiac inotropy in the heart, indicating that this signalling paradigm may be targeted in therapy of heart diseases with reduced ejection fraction.
Source: Cardiovascular Research - Category: Cardiology Source Type: research
More News: Calcium | Cardiology | Cardiovascular | Coreg | Diabetes | Diets | Endocrinology | Heart | Heart Failure | High Fat | Hypertension | Nutrition | Toprol